Our Team

Our Team

Our diverse team members bring with them extensive work experience and expertise in their respective fields. We are dedicated to innovating non-invasive clinical applications for early detection of cancer. We are committed to rigorous testing, data-driven processing, accurate unbiased reporting, and to engineer highly accurate and reliable diagnostic tools. Our goal is to make a significant impact on improving the survivability of cancer.

Thomas Long

Thomas Long

CEO, CFO and Cofounder. He drives business direction, approves company strategies, and oversees financial and risk planning activities.
Cherylle Goebel

Cherylle Goebel

COO, CSO, Cofounder, and SAB. COO, CSO, Cofounder, and SAB. She directs operational strategies and scientific direction, reviews results, and provides risk assessments.
Christopher Louden

Christopher Louden

CIO, Cofounder, and SAB. He directs and evaluates statistical approaches for algorithm development and oversees IT operations.
Dr. Dorothy Wong

Dorothy Wong, MD, JD

Lab Director
Gerald Weiss, MD

Gerald Weiss, MD

Medical Pathologist
Jyothsna Narla, MD

Jyothsna Narla, MD

Medical Pathologist

About Us

Jerry Hurst, MA, CLS, CPHM

Jerry Hurst, MA, CLS, CPHM

Technical Supervisor
Michael Kalinger, CLS, MLS(ASCP)CM

Michael Kalinger, CLS, MLS(ASCP)CM

General Supervisor
Rachel Chuang

Rachel Chuang, PhD

R&D Director. Dr. Chuang has extensive expertise in Molecular and Cellular Biology. She has more than 26 years of experience in research and developed many assays for gene and protein expression.
Nancy Lim

Nancy Lim, PharmD

Regulatory Affairs

Scientific Advisory Board

Dr. Robert McKenna, Jr., MD

Dr. Robert McKenna, Jr., MD

Dr. McKenna pioneered minimally invasive lung cancer surgery. He has more than 30 years of experience as a thoracic surgeon and over 250 peer reviewed publications.
Dr. Andrew Wachtel, MD

Dr. Andrew Wachtel, MD

Dr. Wachtel has been a PI/Sub-PI in more than 41 multi-center research studies and authored numerous peered-reviewed publications. He has over 21 years of experience in Internal, Pulmonary, and Critical Care Medicine.
Cherylle Goebel

Cherylle Goebel

COO, CSO, Cofounder, and SAB. Cherylle has 20 years of project management and over 14 years of R&D experience in genomics and proteomics. She has worked for Kaiser, Thermo (Affymetrix/Pano), and UC Systems.
Christopher Louden

Christopher Louden

CIO, Cofounder, and SAB. He directs and evaluates statistical approaches for algorithm development and oversees IT operations.